Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chinese Angong Niuhuang for Acute Medical Management of Intracerebral Hemorrhage (CALM-ICH) Domain of the APEX-STROKE Adaptive Platform Trial

NCT07752719 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07752719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07752719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chinese Angong Niuhuang for Acute Medical Management of Intracerebral Hemorrhage (CALM-ICH) Domain of the APEX-STROKE Adaptive Platform Trial
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
June 30, 2029
Enrollment
1,100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage, stroke